pmid,title,doi,journal,year,source,query_type
PMID:29982664,EPH receptor signaling as a novel therapeutic target in NF2-deficient meningioma.,10.1093/neuonc/noy046,Neuro-Oncology,2018,synapse,clinical
PMID:39225289,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,e70020,Skin Research and Technology : Official Journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI),2024,synapse,clinical
PMID:41687459,From diagnosis to daily life: A comparative pilot study on healthcare access and challenges for neurofibromatosis type 1 in public systems of Brazil and Portugal.,10.1016/j.clinsp.2026.100875,"Clinics (Sao Paulo, Brazil)",2026,pubmed,clinical
PMID:41602242,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,10.7759/cureus.100193,Cureus,2025,pubmed,clinical
PMID:41598414,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,10.3390/jcm15020475,Journal of clinical medicine,2026,pubmed,clinical
PMID:41527138,Prevalence and management of lower limb segmental overgrowth in patients with NF1: an observational study.,10.1186/s13023-025-04190-5,Orphanet journal of rare diseases,2026,pubmed,clinical
PMID:41487805,Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma.,10.7759/cureus.98336,Cureus,2025,pubmed,clinical
PMID:41399671,Phenotypic characterization of neurofibromatosis type 1 in a large Chinese cohort: A cross-sectional study.,10.1016/j.jdin.2025.09.020,JAAD international,2026,pubmed,clinical
PMID:41341331,"Optic Nerve Glioma, Plexiform Neurofibroma, and Secondary Glaucoma in a Child With a Rare NF1 Variant (p.Gln83Ter): A Case Report.",10.7759/cureus.95957,Cureus,2025,pubmed,clinical
PMID:41299544,Clinical characteristics and healthcare burden of neurofibromatosis type 1 in Saudi Arabia: a single centre experience.,10.1186/s13053-025-00325-8,Hereditary cancer in clinical practice,2025,pubmed,clinical
PMID:41243511,A novel germline ,10.32074/1591-951X-N1157,Pathologica,2025,pubmed,clinical
PMID:41141169,Incidental Adrenal Mass in a Patient With a Known History of Neurofibromatosis: A Case Report.,10.7759/cureus.93008,Cureus,2025,pubmed,clinical
PMID:41124475,"Quality of life of adolescent, children and young adults with neurofibromatosis type 1: a scoping review.",10.1590/1413-812320242911.18252023,Ciencia & saude coletiva,2025,pubmed,clinical
PMID:41036990,[Neurofibromatosis: advances in diagnosis and treatment].,,Medicina,2025,pubmed,clinical
PMID:40991947,Therapeutic Advances in Neurofibromatosis Type 1: A Focus on Selumetinib.,,Skin therapy letter,2025,pubmed,clinical
PMID:40877908,TRAP1 expression elicits pro-tumoral functions in macrophages associated to malignant peripheral nerve sheath tumor cells.,10.1186/s13046-025-03525-1,Journal of experimental & clinical cancer research : CR,2025,pubmed,clinical
PMID:40867225,Optic Pathway Glioma: Current Treatment Approaches and Ongoing Clinical Trials.,10.3390/brainsci15080894,Brain sciences,2025,pubmed,clinical
PMID:40802118,Real-world experience with selumetinib in children with neurofibromatosis type 1: a multicentric retrospective study.,10.1007/s11060-025-05197-5,Journal of neuro-oncology,2025,pubmed,clinical
PMID:40764996,"From genes to therapy: navigating the complex landscape of neurofibromatosis management in Canada through advanced diagnostic, targeted therapies, and holistic care.",10.1186/s13023-025-03793-2,Orphanet journal of rare diseases,2025,pubmed,clinical
PMID:40741214,"Accounting for Biological Sex and Gender Identity in the Pathogenesis, Artistic Depictions, and Quality of Life in Neurofibromatosis Type 1.",10.1016/j.xjidi.2025.100393,JID innovations : skin science from molecules to population health,2025,pubmed,clinical
PMID:40737523,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,10.2196/71728,JMIR human factors,2025,pubmed,clinical
PMID:40684195,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,10.1186/s40478-025-02075-z,Acta neuropathologica communications,2025,pubmed,clinical
PMID:40620752,Long-Term Pulmonary Function after Combined Anteroposterior Spinal Fusion for Scoliosis in Neurofibromatosis Type 1 and Marfan Syndrome at a Mean Follow-Up of 13 Years.,10.1055/s-0045-1809340,Revista brasileira de ortopedia,2025,pubmed,clinical
PMID:40620751,[Long-Term Pulmonary Function after Combined Anteroposterior Spinal Fusion for Scoliosis in Neurofibromatosis Type 1 and Marfan Syndrome at a Mean Follow-Up of 13 Years].,10.1055/s-0045-1809526,Revista brasileira de ortopedia,2025,pubmed,clinical
PMID:40529476,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,10.1016/j.xjidi.2025.100380,JID innovations : skin science from molecules to population health,2025,pubmed,clinical
PMID:40523834,Breast cancer germline multigene panel testing in mainstream oncology based on clinical-public health utility: ESMO Precision Oncology Working Group recommendations.,10.1016/j.annonc.2025.04.012,Annals of oncology : official journal of the European Society for Medical Oncology,2025,pubmed,clinical
PMID:40481533,"The association of body image with quality of life, psychological assistance and social support in neurofibromatosis type 1 patients: a cross-sectional study.",10.1186/s13023-025-03729-w,Orphanet journal of rare diseases,2025,pubmed,clinical
PMID:40471421,Psychosocial functioning and determinants of the health-related quality of life in children with neurofibromatosis type 1 and cognitive impairments.,10.1007/s11060-025-05024-x,Journal of neuro-oncology,2025,pubmed,clinical
PMID:40459753,"Irritability in children with RASopathies, insights into emotional dysregulation and social impairment.",10.1007/s00787-025-02767-w,European child & adolescent psychiatry,2025,pubmed,clinical
PMID:40437318,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,10.1186/s41747-025-00594-x,European radiology experimental,2025,pubmed,clinical
PMID:40408317,"Chronic Pain in Neurofibromatosis 1, Neurofibromatosis 2, and Schwannomatosis: A Review on Epidemiology, Pathophysiology, Symptomatology and Treatment.",,Pain physician,2025,pubmed,clinical
PMID:40406628,Nipple-Areolar Complex Neurotization Following Nipple-sparing Mastectomy and Breast Reconstruction for Solitary Breast Neurofibroma.,10.1097/GOX.0000000000006814,Plastic and reconstructive surgery. Global open,2025,pubmed,clinical
PMID:40394150,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,10.1038/s41416-025-03055-9,British journal of cancer,2025,pubmed,clinical
PMID:40393479,Neurofibromatosis Type 1 : A General Review.,10.3340/jkns.2025.0073,Journal of Korean Neurosurgical Society,2025,pubmed,clinical
PMID:40380173,Three-column osteotomy versus Halo-gravity traction combined with posterior column osteotomy in the treatment of dystrophic neurofibromatosis type 1 kyphoscoliosis: a retrospective comparative cohort study.,10.1186/s13018-025-05842-9,Journal of orthopaedic surgery and research,2025,pubmed,clinical
PMID:40357806,Dentofacial Malocclusion in Neurofibromatosis 1 in Finland.,10.1002/ajmg.a.64110,American journal of medical genetics. Part A,2025,pubmed,clinical
PMID:40348863,Multidisciplinary collaborative treatment of a giant malignant peripheral nerve sheath tumor on the top of the head: a case report.,10.1007/s12672-025-02554-8,Discover oncology,2025,pubmed,clinical
PMID:40342626,Clinical characterization of neuropathic pain and small fiber impairment in neurofibromatosis.,10.1097/PR9.0000000000001285,Pain reports,2025,pubmed,clinical
PMID:40322210,Advanced Metastatic Malignant Triton Tumor in Neurofibromatosis Type 1: A Case Report and Management Challenges.,10.21873/cdp.10454,Cancer diagnosis & prognosis,2025,pubmed,clinical
PMID:40304934,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,10.1186/s41687-025-00877-2,Journal of patient-reported outcomes,2025,pubmed,clinical
PMID:40299482,Sleep Disorders in Pediatric Patients Affected by Neurofibromatosis Type 1: Reports of a Questionnaire and an Apple Watch Sleep Assessment.,10.3390/biomedicines13040907,Biomedicines,2025,pubmed,clinical
PMID:40242369,Novel Risk Factors for Uveal Melanoma in Adolescent and Young Adult Patients: A Comprehensive Case-Control Analysis.,10.1016/j.xops.2024.100687,Ophthalmology science,2025,pubmed,clinical
PMID:40237330,Unveiling the complexity of neurofibromatosis type 1: Innovations in genetic understanding and clinical management. A narrative review.,10.5507/bp.2025.011,"Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia",2025,pubmed,clinical
PMID:40235035,Lifelong Management of Neurofibromatosis 1 Patients.,10.3340/jkns.2025.0057,Journal of Korean Neurosurgical Society,2025,pubmed,clinical
PMID:40225101,Small Intestinal Neurofibroma With Atypical 17q11.2 Microdeletions: A Rare Cause of Abdominal Distension.,10.1002/jgh3.70138,JGH open : an open access journal of gastroenterology and hepatology,2025,pubmed,clinical
PMID:40192953,Clinical Actionability of Molecular Targets in Multi-Ethnic Breast Cancer Patients: A Retrospective Single-Institutional Study.,10.1007/s40291-025-00777-7,Molecular diagnosis & therapy,2025,pubmed,clinical
PMID:40139495,Malignant Peripheral Nerve Sheath Tumors in Children and Adolescents: A Population-Based Study.,10.1016/j.wneu.2025.123934,World neurosurgery,2025,pubmed,clinical
PMID:39952425,Sex-dependent variations of retinal function and architecture in a neurofibromatosis type I mouse model with normal vision.,10.1016/j.exer.2025.110279,Experimental eye research,2025,pubmed,clinical
PMID:39948669,How does a preference-based generic health-related quality of life measure perform in patients with a rare disease? Measurement properties of the EQ-5D-Y proxy version among underage patients with neurofibromatosis type 1.,10.1186/s13023-025-03590-x,Orphanet journal of rare diseases,2025,pubmed,clinical
PMID:39875738,[Plastic surgical treatment of neurofibromatosis type 1].,10.1007/s00104-024-02232-5,"Chirurgie (Heidelberg, Germany)",2025,pubmed,clinical
PMID:39844170,Internalizing and externalizing symptoms in individuals with neurofibromatosis type 1: a systematic review and meta-analysis.,10.1186/s13643-024-02749-0,Systematic reviews,2025,pubmed,clinical
PMID:39835668,"Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas that can't be removed by surgery, and impact on how the condition affects caregivers: a plain language summary.",10.57264/cer-2024-0184,Journal of comparative effectiveness research,2025,pubmed,clinical
PMID:39762421,Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial.,10.1038/s41591-024-03361-4,Nature medicine,2025,pubmed,clinical
PMID:39731804,Surgical management of a large neurofibroma in the thenar Region: A case report.,10.1016/j.ijscr.2024.110742,International journal of surgery case reports,2025,pubmed,clinical
PMID:39684258,"Comprehensive Clinical Genetics, Molecular and Pathological Evaluation Efficiently Assist Diagnostics and Therapy Selection in Breast Cancer Patients with Hereditary Genetic Background.",10.3390/ijms252312546,International journal of molecular sciences,2024,pubmed,clinical
PMID:39666427,[Pituicitoma in a patient with neurofibromatosis type 1].,,Medicina,2024,pubmed,clinical
PMID:39609892,Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study.,10.1186/s13023-024-03454-w,Orphanet journal of rare diseases,2024,pubmed,clinical
PMID:39596296,Integrated Transcriptome Profiling and Pan-Cancer Analyses Reveal Oncogenic Networks and Tumor-Immune Modulatory Roles for FABP7 in Brain Cancers.,10.3390/ijms252212231,International journal of molecular sciences,2024,pubmed,clinical
PMID:39539654,Quality of life of patients with neurofibromatosis 1-Physical disability does not necessarily result in poor mental health.,10.3389/fneur.2024.1432196,Frontiers in neurology,2024,pubmed,clinical
PMID:39514826,"ReNeu: A Pivotal, Phase IIb Trial of Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1-Associated Plexiform Neurofibroma.",10.1200/JCO.24.01034,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2025,pubmed,clinical
PMID:39454246,Effectiveness of CI as an alternative to ABI for hearing loss in patients with vestibular schwannomas: A multicenter study in Japan.,10.1016/j.anl.2024.10.010,"Auris, nasus, larynx",2024,pubmed,clinical
PMID:39433490,[Emergency management and perioperative strategies for intra-tumoral hemorrhage in neurofibromatosis type 1-related giant plexiform neurofibroma].,10.7507/1002-1892.202406074,Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,2024,pubmed,clinical
PMID:39433489,[Progress in neurosurgical treatment of neurofibromatosis type 1].,10.7507/1002-1892.202407058,Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,2024,pubmed,clinical
PMID:39433486,[Several suggestions for improving diagnosis and management of patients with neurofibromatosis type 1].,10.7507/1002-1892.202406062,Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,2024,pubmed,clinical
PMID:39403336,Duodenal ampulla neuroendocrine tumor and gastrointestinal stromal tumors in a case of neurofibromatosis type 1: a case report.,10.3389/fonc.2024.1336539,Frontiers in oncology,2024,pubmed,clinical
PMID:39359760,Managing neurofibromatosis type I and vision impairment in a resource-limited setting: a case study and multidisciplinary approach.,10.1097/MS9.0000000000002482,Annals of medicine and surgery (2012),2024,pubmed,clinical
PMID:39336731,The Prevalence of Cancer Predisposition Syndromes (CPSs) in Children with a Neoplasm: A Cohort Study in a Central and Eastern European Population.,10.3390/genes15091141,Genes,2024,pubmed,clinical
PMID:39257551,Diagnosis and management of neurofibromatosis type 1 in Arabian Gulf Cooperation Council Region: challenges and recommendations.,10.3389/fonc.2024.1323176,Frontiers in oncology,2024,pubmed,clinical
PMID:39234078,"Long-term distress throughout one's life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China.",10.3389/fpubh.2024.1398803,Frontiers in public health,2024,pubmed,clinical
PMID:39211690,Plexiform Neurofibroma: A Case Report.,10.7759/cureus.65747,Cureus,2024,pubmed,clinical
PMID:39210910,Impact of pathogenic variants of the Ras-mitogen-activated protein kinase pathway on major white matter tracts in the human brain.,10.1093/braincomms/fcae274,Brain communications,2024,pubmed,clinical
PMID:39201967,"Quality of Life in Children with Neurofibromatosis Type 1: Agreement between Parents and Patients, and the Role of Disease Severity and Visibility.",10.3390/children11081033,"Children (Basel, Switzerland)",2024,pubmed,clinical
PMID:39198186,Quality of life and neurological symptoms in patients with neurofibromatosis type 2: a national database study in Japan.,10.1265/ehpm.24-00158,Environmental health and preventive medicine,2024,pubmed,clinical
PMID:39196570,Cutaneous Neurofibromas and Quality of Life in Adults With Neurofibromatosis Type 1.,10.1001/jamadermatol.2024.2912,JAMA dermatology,2024,pubmed,clinical
PMID:39185400,Total Knee Arthroplasty in a Patient With Neurofibromatosis 1.,10.1016/j.artd.2024.101453,Arthroplasty today,2024,pubmed,clinical
PMID:39176108,Gene Mutations in Gastrointestinal Stromal Tumors: Advances in Treatment and Mechanism Research.,10.1055/s-0044-1789204,Global medical genetics,2024,pubmed,clinical
PMID:39165673,INTRATHECAL BACLOFEN FOR NEUROFIBROMATOSIS RELATED SPINAL CORD INJURY WITH SPASTICITY - A CASE REPORT.,10.2340/jrm-cc.v7.25912,Journal of rehabilitation medicine. Clinical communications,2024,pubmed,clinical
PMID:39140257,Heterozygosity for loss-of-function variants in LZTR1 is associated with isolated multiple café-au-lait macules.,10.1016/j.gim.2024.101241,Genetics in medicine : official journal of the American College of Medical Genetics,2024,pubmed,clinical
PMID:39083549,Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma.,10.1371/journal.pone.0305121,PloS one,2024,pubmed,clinical
PMID:39022466,"Investigating the Prevalence, Gender Predilection, and Inheritance Patterns of Genodermatoses: A Tertiary Hospital Study.",10.7759/cureus.62455,Cureus,2024,pubmed,clinical
PMID:39002525,Disentangling negative and positive symptoms in schizophrenia and autism spectrum disorder.,10.1016/j.schres.2024.07.002,Schizophrenia research,2024,pubmed,clinical
PMID:38990917,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,10.1371/journal.pone.0305548,PloS one,2024,pubmed,clinical
PMID:38975694,Safety and efficacy of selumetinib in pediatric and adult patients with neurofibromatosis type 1 and plexiform neurofibroma.,10.1093/neuonc/noae121,Neuro-oncology,2024,pubmed,clinical
PMID:38923593,The impact of cutaneous neurofibromas on quality of life and mental health in neurofibromatosis type 1.,10.1111/1346-8138.17276,The Journal of dermatology,2024,pubmed,clinical
PMID:38923198,Adaption of neurosurgical resection patterns for pediatric low-grade glioma spanning two decades-Report from the German LGG-studies 1996-2018.,10.1002/cam4.7417,Cancer medicine,2024,pubmed,clinical
PMID:38918262,Surgical options of chiasmatic hypothalamic glioma-a relevant part of therapy in an interdisciplinary approach for tumor control.,10.1007/s00381-024-06498-2,Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,2024,pubmed,clinical
PMID:38869947,Selumetinib for children with neurofibromatosis type 1 and plexiform neurofibromas: A plain language summary of SPRINT.,10.2217/fon-2023-0565,"Future oncology (London, England)",2024,pubmed,clinical
PMID:38811427,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,10.1186/s41687-024-00732-w,Journal of patient-reported outcomes,2024,pubmed,clinical
PMID:38769783,Surgical Treatment Outcomes of Anterior-Only Correction and Reconstruction for Severe Cervical Kyphotic Deformity with Neurofibromatosis-1: A Retrospective Study with a 5-Year Follow-Up.,10.1111/os.14096,Orthopaedic surgery,2024,pubmed,clinical
PMID:38703433,Tumors of the nervous system and hearing loss: Beyond vestibular schwannomas.,10.1016/j.heares.2024.109012,Hearing research,2024,pubmed,clinical
PMID:38680880,Neurofibromatosis Type 1: Optimizing Management with a Multidisciplinary Approach.,10.2147/JMDH.S362791,Journal of multidisciplinary healthcare,2024,pubmed,clinical
PMID:38654147,Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.,10.1186/s12872-024-03878-z,BMC cardiovascular disorders,2024,pubmed,clinical
PMID:38623309,Supplementation of Heat-Treated ,10.1155/2024/5558566,Journal of nutrition and metabolism,2024,pubmed,clinical
PMID:38595983,Conditionally replicative adenovirus as a therapy for malignant peripheral nerve sheath tumors.,10.1016/j.omton.2024.200783,Molecular therapy. Oncology,2024,pubmed,clinical
PMID:38592693,The Lack of Ad Hoc Neuropsychological Assessment in Adults with Neurofibromatosis: A Systematic Review.,10.3390/jcm13051432,Journal of clinical medicine,2024,pubmed,clinical
PMID:38560379,Endocrine and non-endocrine causes of fatigue in adults with Neurofibromatosis type 1.,10.3389/fendo.2023.1119159,Frontiers in endocrinology,2023,pubmed,clinical
PMID:38542016,Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management.,10.3390/jcm13061792,Journal of clinical medicine,2024,pubmed,clinical
PMID:38521834,The impact of mental health on health-related quality of life in patients with NF2-related Schwannomatosis.,10.1038/s41598-024-57401-7,Scientific reports,2024,pubmed,clinical
PMID:38499890,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",10.1186/s41687-024-00714-y,Journal of patient-reported outcomes,2024,pubmed,clinical
PMID:38493052,Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study.,10.1016/j.abd.2023.08.011,Anais brasileiros de dermatologia,2024,pubmed,clinical
PMID:38465768,Very long-term outcomes of pediatric patients treated for optic pathway gliomas: A longitudinal cohort study.,10.1093/neuonc/noae045,Neuro-oncology,2024,pubmed,clinical
PMID:38409461,Diverse learners: learning disabilities and quality of life following mind-body and health education interventions for adults with neurofibromatosis.,10.1007/s11060-024-04610-9,Journal of neuro-oncology,2024,pubmed,clinical
PMID:38402381,Impact of neurofibromatosis type 1 on quality of life using the Skindex-29 questionnaire quality of life in NF1.,10.1186/s13023-024-03078-0,Orphanet journal of rare diseases,2024,pubmed,clinical
PMID:38372904,Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma.,10.1007/s11060-024-04596-4,Journal of neuro-oncology,2024,pubmed,clinical
PMID:38366576,Perceived transition readiness among adolescents and young adults with neurofibromatosis type 1 and plexiform neurofibromas: a cross-sectional descriptive study.,10.1093/jpepsy/jsae006,Journal of pediatric psychology,2024,pubmed,clinical
PMID:38321701,Patient-reported measures of tinnitus for individuals with neurofibromatosis type 2-related schwannomatosis: Recommendations for clinical trials.,10.1177/17407745231217279,"Clinical trials (London, England)",2024,pubmed,clinical
PMID:38318960,The impact of a virtual mind-body program on symptoms of depression and anxiety among international English-speaking adults with neurofibromatosis.,10.1002/ajmg.a.63543,American journal of medical genetics. Part A,2024,pubmed,clinical
PMID:38279591,Global research trends in cutaneous neurofibromas: A bibliometric analysis from 2003 to 2022.,10.1111/srt.13595,Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI),2024,pubmed,clinical
PMID:38260834,Case report: Benign and malignant tumors in adult patients with neurofibromatosis type 1: a comprehensive case series from a large oncologic reference center.,10.3389/fonc.2023.1291286,Frontiers in oncology,2023,pubmed,clinical
PMID:38187038,Novel combination of imipridones and histone deacetylase inhibitors demonstrate cytotoxic effect through integrated stress response in pediatric solid tumors.,,American journal of cancer research,2023,pubmed,clinical
PMID:38175707,Unbalancing cAMP and Ras/MAPK pathways as a therapeutic strategy for cutaneous neurofibromas.,10.1172/jci.insight.168826,JCI insight,2024,pubmed,clinical
PMID:38173515,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,10.1016/j.heliyon.2023.e23445,Heliyon,2024,pubmed,clinical
PMID:38170419,Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.,10.1007/s11136-023-03574-z,"Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation",2024,pubmed,clinical
PMID:40608383,The Combined Use of Acute Regional and Interventional Pain Offers Superior Quality of Life in Palliative Care.,,Pain medicine case reports,2024,pubmed,clinical
PMID:38140900,Recommendations for assessing appearance concerns related to plexiform and cutaneous neurofibromas in neurofibromatosis 1 clinical trials.,10.1177/17407745231205577,"Clinical trials (London, England)",2024,pubmed,clinical
PMID:38114312,[Application of peroral endoscopic-assisted laryngeal microsurgery in children with laryngeal neurofibromas].,10.13201/j.issn.2096-7993.2023.12.006,Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery,2023,pubmed,clinical
PMID:38057084,Quality of life in patients with neurofibromatosis type 1: a nationwide database study in Japan from 2015 to 2019.,10.1265/ehpm.23-00221,Environmental health and preventive medicine,2023,pubmed,clinical
PMID:38009710,"Mindfulness, coping, and optimism as mechanisms of change in the 3RP-NF intervention.",10.1002/jclp.23623,Journal of clinical psychology,2024,pubmed,clinical
PMID:38000811,Epithelioid malignant peripheral nerve sheath tumour of the ulnar nerve around the elbow: a diagnostic and therapeutic challenge.,10.1136/bcr-2023-256900,BMJ case reports,2023,pubmed,clinical
PMID:37996843,Impact of neurofibromatosis type 1 with plexiform neurofibromas on the health-related quality of life and work productivity of adult patients and caregivers in the UK: a cross-sectional survey.,10.1186/s12883-023-03429-7,BMC neurology,2023,pubmed,clinical
PMID:37962219,Perspectives of adults with neurofibromatosis regarding the design of psychosocial trials: Results from an anonymous online survey.,10.1177/17407745231209224,"Clinical trials (London, England)",2024,pubmed,clinical
PMID:37958460,"Oncological Outcomes, Long-Term Toxicities, Quality of Life and Sexual Health after Pencil-Beam Scanning Proton Therapy in Patients with Low-Grade Glioma.",10.3390/cancers15215287,Cancers,2023,pubmed,clinical
PMID:37791039,Severe Untreated Scoliosis and Early Onset Breast Cancer in a Patient with Neurofibromatosis Associated with a Nonsense Variant of ,10.2147/ORR.S415978,Orthopedic research and reviews,2023,pubmed,clinical
PMID:37732340,"Coexistence of a small bowel gastrointestinal stromal tumor, small bowel adenocarcinoma and ganglioneuroma in a patient with neurofibromatosis type I caused intussusception.",10.17235/reed.2023.9896/2023,Revista espanola de enfermedades digestivas,2024,pubmed,clinical
PMID:37728798,[Cosmetic and functional results after resection of cutaneous neurofibroma in neurofibromatosis type 1 : Operation of neurofibroma improves quality of life while having moderate complications].,10.1007/s00105-023-05220-8,"Dermatologie (Heidelberg, Germany)",2022,pubmed,clinical
PMID:37616542,"Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor.",10.1158/1535-7163.MCT-23-0258,Molecular cancer therapeutics,2023,pubmed,clinical
PMID:37509275,Sensory Processing in Children and Adolescents with Neurofibromatosis Type 1.,10.3390/cancers15143612,Cancers,2023,pubmed,clinical
PMID:37440099,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,10.1007/s11060-023-04389-1,Journal of neuro-oncology,2023,pubmed,clinical
PMID:37417633,Renal artery aneurysm induced by neurofibromatosis type 1: A case report and review of the endovascular interventions for this rare vasculopathy.,10.1097/MD.0000000000034216,Medicine,2023,pubmed,clinical
PMID:37378983,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,10.1001/jamanetworkopen.2023.20599,JAMA network open,2023,pubmed,clinical
PMID:37353850,Burden of adult neurofibromatosis 1 questionnaire: translation and psychometric properties of the Persian version.,10.1186/s13023-023-02681-x,Orphanet journal of rare diseases,2023,pubmed,clinical
PMID:37328781,Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas.,10.1186/s12885-023-10996-y,BMC cancer,2023,pubmed,clinical
PMID:37294265,Multidisciplinary Outpatient Clinic of Neurocutaneous Diseases: Five-year Experience of a Pediatric Tertiary Hospital in Portugal.,10.20344/amp.19063,Acta medica portuguesa,2024,pubmed,clinical
PMID:37287695,"Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study.",10.1093/noajnl/vdad054,Neuro-oncology advances,2023,pubmed,clinical
PMID:37276689,Health-related quality of life of children with neurofibromatosis type 1: Analysis of proxy-rated PedsQL and CHQ questionnaires.,10.1016/j.ejpn.2023.05.010,European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society,2023,pubmed,clinical
PMID:37275115,Managing Multiple Schwannomatosis of Vagus and Hypoglossal Nerves: The Unanticipated Complications.,10.1007/s12070-022-03460-z,Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India,2023,pubmed,clinical
PMID:37173460,Neurofibromatosis type 1-associated plexiform neurofibromas of the neck: topography of lesions and surgical treatment data of 69 patients.,10.1007/s10006-023-01155-5,Oral and maxillofacial surgery,2024,pubmed,clinical
PMID:37115514,Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.,10.1093/neuonc/noad086,Neuro-oncology,2023,pubmed,clinical
PMID:37010875,"Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.",10.1093/neuonc/noad066,Neuro-oncology,2023,pubmed,clinical
PMID:36996759,Motor Function and Physiology in Youth With Neurofibromatosis Type 1.,10.1016/j.pediatrneurol.2023.02.014,Pediatric neurology,2023,pubmed,clinical
PMID:36895472,MEK inhibition causes BIM stabilization and increased sensitivity to BCL-2 family member inhibitors in RAS-MAPK-mutated neuroblastoma.,10.3389/fonc.2023.1130034,Frontiers in oncology,2023,pubmed,clinical
PMID:36857802,Rare malignant peripheral nerve sheath tumor of vagus nerve: A case report.,10.1016/j.ijscr.2023.107940,International journal of surgery case reports,2023,pubmed,clinical
PMID:36832459,"Neuropsychiatric Manifestations, Reduced Self-Esteem and Poor Quality of Life in Children and Adolescents with Neurofibromatosis Type 1 (NF1): The Impact of Symptom Visibility and Bullying Behavior.",10.3390/children10020330,"Children (Basel, Switzerland)",2023,pubmed,clinical
PMID:36823650,"Psychosocial implications of rare genetic skin diseases affecting appearance on daily life experiences, emotional state, self-perception and quality of life in adults: a systematic review.",10.1186/s13023-023-02629-1,Orphanet journal of rare diseases,2023,pubmed,clinical
PMID:36684394,ERN GENTURIS tumour surveillance guidelines for individuals with neurofibromatosis type 1.,10.1016/j.eclinm.2022.101818,EClinicalMedicine,2023,pubmed,clinical
PMID:36604703,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,10.1186/s13023-022-02607-z,Orphanet journal of rare diseases,2023,pubmed,clinical
PMID:36598023,Safety and Efficacy of Mek Inhibitors in the Treatment of Plexiform Neurofibromas: A Retrospective Study.,10.1177/10732748221144930,Cancer control : journal of the Moffitt Cancer Center,2023,pubmed,clinical
PMID:36444392,Characterization of health concerns in people with neurofibromatosis type 1.,10.1002/mgg3.2077,Molecular genetics & genomic medicine,2023,pubmed,clinical
PMID:36405824,Neuroblastic tumors and neurofibromatosis type 1: A retrospective multicenter study in Italy and systematic review of the literature.,10.3389/fped.2022.950911,Frontiers in pediatrics,2022,pubmed,clinical
PMID:36332985,Ten-Year Follow-up of Internal Neurofibroma Growth Behavior in Adult Patients With Neurofibromatosis Type 1 Using Whole-Body MRI.,10.1212/WNL.0000000000201535,Neurology,2023,pubmed,clinical
PMID:36215287,Cognitive and behavioral functioning in two neurogenetic disorders; how different are these aspects in Duchenne muscular dystrophy and Neurofibromatosis type 1?,10.1371/journal.pone.0275803,PloS one,2022,pubmed,clinical
PMID:36127977,Vertebral Artery Stenosis: A Narrative Review.,10.7759/cureus.28068,Cureus,2022,pubmed,clinical
PMID:36127120,Cohort profile: life with neurofibromatosis 1 - the Danish NF1 cohort.,10.1136/bmjopen-2022-065340,BMJ open,2022,pubmed,clinical
PMID:36111466,[Treatment and progress of cutaneous neurofibroma].,10.7507/1002-1892.202205072,Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,2022,pubmed,clinical
PMID:36081238,Plasticity of visual evoked potentials in patients with neurofibromatosis type 1.,10.1016/j.clinph.2022.08.009,Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,2022,pubmed,clinical
PMID:36037004,Mechanistic insights from animal models of neurofibromatosis type 1 cognitive impairment.,10.1242/dmm.049422,Disease models & mechanisms,2022,pubmed,clinical
PMID:35970940,"Cortical inhibition in neurofibromatosis type 1 is modulated by lovastatin, as demonstrated by a randomized, triple-blind, placebo-controlled clinical trial.",10.1038/s41598-022-17873-x,Scientific reports,2022,pubmed,clinical
PMID:35854908,Surgical treatment of common peroneal neuropathy in schwannomatosis: illustrative cases.,10.3171/CASE21176,Journal of neurosurgery. Case lessons,2021,pubmed,clinical
PMID:35784925,Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience.,10.3389/fsurg.2022.890875,Frontiers in surgery,2022,pubmed,clinical
PMID:35759947,A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.,10.1016/j.pediatrneurol.2022.06.003,Pediatric neurology,2022,pubmed,clinical
PMID:35758466,NEUROFIBROMATOSIS TYPE I AND ITS DIAGNOSTIC CRITERIA: A CLINICAL OBSERVATION.,10.36740/WLek202205231,"Wiadomosci lekarskie (Warsaw, Poland : 1960)",2022,pubmed,clinical
PMID:35756263,Sexual Self-Esteem and Psychological Burden of Adults With Neurofibromatosis Type 1.,10.3389/fpsyg.2022.883019,Frontiers in psychology,2022,pubmed,clinical
PMID:35740497,Treatment of Gastrointestinal Stromal Tumors (GISTs): A Focus on Younger Patients.,10.3390/cancers14122831,Cancers,2022,pubmed,clinical
PMID:35729665,Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.,10.1186/s13023-022-02379-6,Orphanet journal of rare diseases,2022,pubmed,clinical
PMID:35723774,A randomized controlled trial of remote microphone listening devices to treat auditory deficits in children with neurofibromatosis type 1.,10.1007/s10072-022-06203-8,Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology,2022,pubmed,clinical
PMID:35679001,Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study.,10.1007/s40120-022-00365-5,Neurology and therapy,2022,pubmed,clinical
PMID:35601964,Impact of neurofibromatosis type 1 in an adult community population.,10.1093/nop/npac014,Neuro-oncology practice,2022,pubmed,clinical
PMID:35597953,Transition to adult care of young patients with neurofibromatosis type 1 and cognitive deficits: a single-centre study.,10.1186/s13023-022-02356-z,Orphanet journal of rare diseases,2022,pubmed,clinical
PMID:35579709,Clinical and humanistic burden among pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma in the USA.,10.1007/s00381-022-05513-8,Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,2022,pubmed,clinical
PMID:35546306,"A systematic review and meta-analysis of intellectual, neuropsychological, and psychoeducational functioning in neurofibromatosis type 1.",10.1002/ajmg.a.62773,American journal of medical genetics. Part A,2022,pubmed,clinical
PMID:35545829,Recent Update in Pharmacological Agents for Optic Pathway Glioma.,10.14791/btrt.2022.0006,Brain tumor research and treatment,2022,pubmed,clinical
PMID:35467749,Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity.,10.1093/neuonc/noac109,Neuro-oncology,2022,pubmed,clinical
PMID:35394491,Function of the Retinal Pigment Epithelium in Patients With Neurofibromatosis Type 1.,10.1167/iovs.63.4.6,Investigative ophthalmology & visual science,2022,pubmed,clinical
PMID:35371718,A Clinico-Epidemiological Study of Neurofibromatosis Type 1 and Its Relation to Quality of Life: A Cross-Sectional Study From India.,10.7759/cureus.22376,Cureus,2022,pubmed,clinical
PMID:35328218,Diencephalic Syndrome Due to Optic Pathway Gliomas in Pediatric Patients: An Italian Multicenter Study.,10.3390/diagnostics12030664,"Diagnostics (Basel, Switzerland)",2022,pubmed,clinical
PMID:35135568,A cross-sectional study of gender differences in quality of life domains in patients with neurofibromatosis type 1.,10.1186/s13023-022-02195-y,Orphanet journal of rare diseases,2022,pubmed,clinical
PMID:35004058,Assessing Psychiatric Comorbidity and Pharmacologic Treatment Patterns Among Patients With Neurofibromatosis Type 1.,10.7759/cureus.20244,Cureus,2021,pubmed,clinical
PMID:34983638,Delineating the autistic phenotype in children with neurofibromatosis type 1.,10.1186/s13229-021-00481-3,Molecular autism,2022,pubmed,clinical
PMID:34897289,Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study.,10.1038/s41431-021-01015-4,European journal of human genetics : EJHG,2022,pubmed,clinical
PMID:34870681,Auditory Dysfunction Among Individuals With Neurofibromatosis Type 1.,10.1001/jamanetworkopen.2021.36842,JAMA network open,2021,pubmed,clinical
PMID:34793666,Implication and Influence of Multigene Panel Testing with Genetic Counseling in Korean Patients with BRCA1/2 Mutation-Negative Breast Cancer.,10.4143/crt.2021.978,Cancer research and treatment,2022,pubmed,clinical
PMID:34779163,[Expert consensus on diagnosis and management of neurofibromatosis type 1 (2021 edition)].,10.7507/1002-1892.202108065,Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,2021,pubmed,clinical
PMID:34768015,Treatment of cutaneous neurofibromas with carbon dioxide laser: Technique and patient experience.,10.1016/j.ejmg.2021.104386,European journal of medical genetics,2022,pubmed,clinical
PMID:34627329,Executive functions and quality of life in children with neurofibromatosis type 1.,10.1186/s13023-021-02051-5,Orphanet journal of rare diseases,2021,pubmed,clinical
PMID:34570301,Psychological resiliency explains the relationship between emotional distress and quality of life in neurofibromatosis.,10.1007/s11060-021-03852-1,Journal of neuro-oncology,2021,pubmed,clinical
PMID:34430126,Complications of Neurofibromatosis 1 (NF1) in an Adult With Multiple Comorbidities.,10.7759/cureus.16512,Cureus,2021,pubmed,clinical
PMID:34422615,The Patients' Experiences of Burden of Neurofibromatosis: A Qualitative Study.,10.4103/ijnmr.IJNMR_178_20,Iranian journal of nursing and midwifery research,2021,pubmed,clinical
PMID:34416167,Anti-PD-1/L1 lead-in before MAPK inhibitor combination maximizes antitumor immunity and efficacy.,10.1016/j.ccell.2021.07.023,Cancer cell,2021,pubmed,clinical
PMID:34409538,Depression explains the association between pain intensity and pain interference among adults with neurofibromatosis.,10.1007/s11060-021-03826-3,Journal of neuro-oncology,2021,pubmed,clinical
PMID:34230208,Enhancing Neurofibromatosis Clinical Trial Outcome Measures Through Patient Engagement: Lessons From REiNS.,10.1212/WNL.0000000000012430,Neurology,2021,pubmed,clinical
PMID:34230205,Recommendations for Social Skills End Points for Clinical Trials in Neurofibromatosis Type 1.,10.1212/WNL.0000000000012422,Neurology,2021,pubmed,clinical
PMID:34230204,Measuring the Effect of Cutaneous Neurofibromas on Quality of Life in Neurofibromatosis Type 1.,10.1212/WNL.0000000000012427,Neurology,2021,pubmed,clinical
PMID:34230203,Patient Report of Hearing in Neurofibromatosis Type 2: Recommendations for Clinical Trials.,10.1212/WNL.0000000000012424,Neurology,2021,pubmed,clinical
PMID:34230198,Current Recommendations for Patient-Reported Outcome Measures Assessing Domains of Quality of Life in Neurofibromatosis Clinical Trials.,10.1212/WNL.0000000000012421,Neurology,2021,pubmed,clinical
PMID:34230196,Reliability of Handheld Dynamometry to Measure Focal Muscle Weakness in Neurofibromatosis Types 1 and 2.,10.1212/WNL.0000000000012439,Neurology,2021,pubmed,clinical
PMID:34215596,Acceptance and commitment therapy meets peer-support. Development of a supportive self-care intervention for patients with rare diseases: a multistage development process.,10.1136/bmjopen-2020-042856,BMJ open,2021,pubmed,clinical
PMID:34199217,Severe Phenotype in Patients with Large Deletions of ,10.3390/cancers13122963,Cancers,2021,pubmed,clinical
PMID:34155781,L-carnitine supplementation for muscle weakness and fatigue in children with neurofibromatosis type 1: A Phase 2a clinical trial.,10.1002/ajmg.a.62392,American journal of medical genetics. Part A,2021,pubmed,clinical
PMID:34123937,Efficacy of Cannabinoids on Spasticity and Chronic Pain in a Patient with Co-occurrence of Multiple Sclerosis and Neurofibromatosis Type 1.,10.12890/2021_002424,European journal of case reports in internal medicine,2021,pubmed,clinical
PMID:34040477,Natural History and Disease Burden of Neurofibromatosis Type 1 with Plexiform Neurofibromas: A Systematic Literature Review.,10.2147/AHMT.S303456,"Adolescent health, medicine and therapeutics",2021,pubmed,clinical
PMID:34020694,"The mediating effects of quality of life, depression, and generalized anxiety on perceived barriers to employment success for people diagnosed with Neurofibromatosis Type 1.",10.1186/s13023-021-01866-6,Orphanet journal of rare diseases,2021,pubmed,clinical
PMID:33963463,The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1.,10.1007/s10689-021-00259-9,Familial cancer,2022,pubmed,clinical
PMID:33954070,Chronic Lymphocytic Leukemia in Neurofibromatosis Type 1 Patients: Case Report and Literature Review of a Rare Occurrence.,10.7759/cureus.14258,Cureus,2021,pubmed,clinical
PMID:33911094,"Exploring associations between constipation, severity of neurofibromatosis type 1 and NF1 mutational spectrum.",10.1038/s41598-021-87686-x,Scientific reports,2021,pubmed,clinical
PMID:33903738,Identifying challenges in neurofibromatosis: a modified Delphi procedure.,10.1038/s41431-021-00892-z,European journal of human genetics : EJHG,2021,pubmed,clinical
PMID:33817379,Clinical assessment of the use of topical liquid diclofenac following laser microporation of cutaneous neurofibromas in individuals with neurofibromatosis type 1.,10.1016/j.heliyon.2021.e06518,Heliyon,2021,pubmed,clinical
PMID:33734413,Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.,10.1001/jamanetworkopen.2021.0945,JAMA network open,2021,pubmed,clinical
PMID:33671872,Risk Factors for Bullying Victimization in Children with Neurofibromatosis Type 1 (NF1).,10.3390/children8020145,"Children (Basel, Switzerland)",2021,pubmed,clinical
PMID:33625502,"Efficacy of a Brief, Peer-Delivered Self-management Intervention for Patients With Rare Chronic Diseases: A Randomized Clinical Trial.",10.1001/jamapsychiatry.2020.4783,JAMA psychiatry,2021,pubmed,clinical
PMID:33543019,Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker.,10.1016/j.mbplus.2020.100021,Matrix biology plus,2020,pubmed,clinical
PMID:33507822,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,10.1200/JCO.20.02220,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2021,pubmed,clinical
PMID:33507258,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,10.1001/jamanetworkopen.2020.35479,JAMA network open,2021,pubmed,clinical
PMID:33442015,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,10.1038/s41591-020-01193-6,Nature medicine,2021,pubmed,clinical
PMID:33436083,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,10.1186/s13072-020-00380-6,Epigenetics & chromatin,2021,pubmed,clinical
PMID:33413690,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,10.1186/s40478-020-01103-4,Acta neuropathologica communications,2021,pubmed,clinical
PMID:33240020,Clinical picture and treatment of cutaneous lesions in patients with neurofibromatosis type 1.,10.5114/ada.2020.100488,Postepy dermatologii i alergologii,2020,pubmed,clinical
PMID:33197677,Effects of a mind-body program on symptoms of depression and perceived stress among adults with neurofibromatosis type 2 who are deaf: A live-video randomized controlled trial.,10.1016/j.ctim.2020.102581,Complementary therapies in medicine,2021,pubmed,clinical
PMID:33085177,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,10.1002/mgg3.1530,Molecular genetics & genomic medicine,2020,pubmed,clinical
PMID:32977190,Motor cortical excitability and plasticity in patients with neurofibromatosis type 1.,10.1016/j.clinph.2020.08.016,Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology,2020,pubmed,clinical
PMID:32908010,Satisfaction from surgical treatment and its influence on the wellbeing of patients with Recklinghausen disease - preliminary report.,10.5604/01.3001.0014.1541,Polski przeglad chirurgiczny,2020,pubmed,clinical
PMID:32847614,Transcriptional regulatory networks of tumor-associated macrophages that drive malignancy in mesenchymal glioblastoma.,10.1186/s13059-020-02140-x,Genome biology,2020,pubmed,clinical
PMID:32801276,"Social Independence of Patients with Neurofibromatosis Type 2 in Japan: Analysis of a National Registry of Patients Receiving Medical Expense Subsidies, 2004-2013.",10.2176/nmc.oa.2020-0106,Neurologia medico-chirurgica,2020,pubmed,clinical
PMID:32642740,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,10.1093/noajnl/vdaa003,Neuro-oncology advances,2020,pubmed,clinical
PMID:32642739,Clinical trial design in neurofibromatosis type 1 as a model for other tumor predisposition syndromes.,10.1093/noajnl/vdaa017,Neuro-oncology advances,2020,pubmed,clinical
PMID:32642737,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,10.1093/noajnl/vdz050,Neuro-oncology advances,2020,pubmed,clinical
PMID:32630080,Non-Autogenous Innovative Reconstruction Method Following Mandibulectomy.,10.3390/medicina56070326,"Medicina (Kaunas, Lithuania)",2020,pubmed,clinical
PMID:32443592,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,10.3390/ijms21103569,International journal of molecular sciences,2020,pubmed,clinical
PMID:32423401,Cardiac overload resolved by resection of a large plexiform neurofibroma on both the buttocks and upper posterior thighs in a patient with neurofibromatosis type I: a case report.,10.1186/s12893-020-00761-4,BMC surgery,2020,pubmed,clinical
PMID:32406525,Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.,10.1111/dmcn.14558,Developmental medicine and child neurology,2021,pubmed,clinical
PMID:32353955,New Model Systems and the Development of Targeted Therapies for the Treatment of Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors.,10.3390/genes11050477,Genes,2020,pubmed,clinical
PMID:32294191,Pretreatment Endocrine Disorders Due to Optic Pathway Gliomas in Pediatric Neurofibromatosis Type 1: Multicenter Study.,10.1210/clinem/dgaa138,The Journal of clinical endocrinology and metabolism,2020,pubmed,clinical
PMID:32190165,Auditory Brainstem Implantation for Adults With Neurofibromatosis 2 or Severe Inner Ear Abnormalities: A Health Technology Assessment.,,Ontario health technology assessment series,2020,pubmed,clinical
PMID:32187457,Selumetinib in Children with Inoperable Plexiform Neurofibromas.,10.1056/NEJMoa1912735,The New England journal of medicine,2020,pubmed,clinical
PMID:32181506,Social skills and autism spectrum disorder symptoms in children with neurofibromatosis type 1: evidence for clinical trial outcomes.,10.1111/dmcn.14517,Developmental medicine and child neurology,2020,pubmed,clinical
PMID:32176143,Contextualizing the Modern Epidemiology of Neurofibromatosis Type 2 in an Era of Heightened Detection of Sporadic Vestibular Schwannoma.,10.1097/MAO.0000000000002557,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",2020,pubmed,clinical
PMID:32108657,Diagnostic sequence for early diagnosis of neurofibromatosis type 1 using NIH criteria.,,Stomatologija,2019,pubmed,clinical
PMID:32089640,Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023).,10.1155/2020/5784876,Sarcoma,2020,pubmed,clinical
PMID:32014052,Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.,10.1186/s13023-020-1310-3,Orphanet journal of rare diseases,2020,pubmed,clinical
PMID:31937162,Malignant peripheral nerve sheath tumor in the nasopharynx and oropharynx: a case report.,10.1177/0300060519897184,The Journal of international medical research,2020,pubmed,clinical
PMID:31915440,Attention Deficit Predicts Intellectual Functioning in Children with Neurofibromatosis Type 1.,10.1155/2019/9493837,International journal of pediatrics,2019,pubmed,clinical
PMID:31881853,A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01.,10.1186/s12885-019-6442-2,BMC cancer,2019,pubmed,clinical
PMID:31801570,"Cutaneous neurofibromas: patients' medical burden, current management and therapeutic expectations: results from an online European patient community survey.",10.1186/s13023-019-1265-4,Orphanet journal of rare diseases,2019,pubmed,clinical
PMID:31626572,"Multicenter, Prospective, Phase II and Biomarker Study of High-Dose Bevacizumab as Induction Therapy in Patients With Neurofibromatosis Type 2 and Progressive Vestibular Schwannoma.",10.1200/JCO.19.01367,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2019,pubmed,clinical
PMID:31558455,Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.,10.1136/bmjopen-2019-030601,BMJ open,2019,pubmed,clinical
PMID:31438995,Segmental schwannomatosis: characteristics in 12 patients.,10.1186/s13023-019-1176-4,Orphanet journal of rare diseases,2019,pubmed,clinical
PMID:31189476,Evaluation of QoL in neurofibromatosis patients: a systematic review and meta-analysis study.,10.1186/s12883-019-1338-y,BMC neurology,2019,pubmed,clinical
PMID:31081992,"Speech difficulties and patient health communication mediating effects on worry and health-related quality of life in children, adolescents, and young adults with Neurofibromatosis Type 1.",10.1002/ajmg.a.61197,American journal of medical genetics. Part A,2019,pubmed,clinical
PMID:31053133,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,10.1186/s13023-019-1067-8,Orphanet journal of rare diseases,2019,pubmed,clinical
PMID:31013682,The ERK MAPK Pathway Is Essential for Skeletal Development and Homeostasis.,10.3390/ijms20081803,International journal of molecular sciences,2019,pubmed,clinical
PMID:31009417,Towards a neurobiological understanding of pain in neurofibromatosis type 1: mechanisms and implications for treatment.,10.1097/j.pain.0000000000001486,Pain,2019,pubmed,clinical
PMID:30859021,Neurofibromatosis Type 1: Review of Cutaneous and Subcutaneous Tumor Treatment on Quality of Life.,10.1097/GOX.0000000000001982,Plastic and reconstructive surgery. Global open,2019,pubmed,clinical
PMID:30800298,A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1.,10.1177/2050312119829680,SAGE open medicine,2019,pubmed,clinical
PMID:30737893,"Substantial pain burden in frequency, intensity, interference and chronicity among children and adults with neurofibromatosis Type 1.",10.1002/ajmg.a.61069,American journal of medical genetics. Part A,2019,pubmed,clinical
PMID:30615146,Preclinical assessment of MEK1/2 inhibitors for neurofibromatosis type 2-associated schwannomas reveals differences in efficacy and drug resistance development.,10.1093/neuonc/noz002,Neuro-oncology,2019,pubmed,clinical
PMID:30284154,"Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis-1 with Everolimus: A Phase II, Open-Label, Single-Arm Trial.",10.1007/s40268-018-0248-6,Drugs in R&D,2018,pubmed,clinical
PMID:30282421,"Simultaneous reconstruction of the forearm extensor compartment tendon, soft tissue, and skin.",10.5999/aps.2017.01802,Archives of plastic surgery,2018,pubmed,clinical
PMID:30166301,Effects of methylphenidate on cognition and behaviour in children with neurofibromatosis type 1: a study protocol for a randomised placebo-controlled crossover trial.,10.1136/bmjopen-2018-021800,BMJ open,2018,pubmed,clinical
PMID:29987133,Clinical trial design for cutaneous neurofibromas.,10.1212/WNL.0000000000005790,Neurology,2018,pubmed,clinical
PMID:29966337,In Vitro Transcriptome Response to a Mixture of ,10.3390/ijms19071923,International journal of molecular sciences,2018,pubmed,clinical
PMID:29914349,Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.,10.1186/s11689-018-9239-8,Journal of neurodevelopmental disorders,2018,pubmed,clinical
PMID:29718344,Association of plexiform neurofibroma volume changes and development of clinical morbidities in neurofibromatosis 1.,10.1093/neuonc/noy067,Neuro-oncology,2018,pubmed,clinical
PMID:29670726,"Decayed, missing, and restored teeth in patients with Neurofibromatosis Type 1.",10.4317/jced.54561,Journal of clinical and experimental dentistry,2018,pubmed,clinical
PMID:29659143,RASopathies are associated with a distinct personality profile.,10.1002/ajmg.b.32632,"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics",2018,pubmed,clinical
PMID:29649040,Improvement in Patient-reported Hearing After Treatment With Bevacizumab in People With Neurofibromatosis Type 2.,10.1097/MAO.0000000000001781,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",2018,pubmed,clinical
PMID:29570943,"The Relationship Between Heart Rate Variability, Psychological Flexibility, and Pain in Neurofibromatosis Type 1.",10.1111/papr.12695,Pain practice : the official journal of World Institute of Pain,2018,pubmed,clinical
PMID:29423604,Autism Spectrum Disorder in an Unselected Cohort of Children with Neurofibromatosis Type 1 (NF1).,10.1007/s10803-018-3478-0,Journal of autism and developmental disorders,2018,pubmed,clinical
PMID:29415745,Cutaneous neurofibromas in Neurofibromatosis type I: a quantitative natural history study.,10.1186/s13023-018-0772-z,Orphanet journal of rare diseases,2018,pubmed,clinical
PMID:29402968,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,10.1038/s41598-018-20894-0,Scientific reports,2018,pubmed,clinical
PMID:29384852,Pain correlates with germline mutation in schwannomatosis.,10.1097/MD.0000000000009717,Medicine,2018,pubmed,clinical
PMID:29372092,Intravenous Remifentanil Analgaesia for an Obstetric Patient with Type I Neurofibromatosis and a Factor V Leiden Mutation.,10.18295/squmj.2017.17.04.016,Sultan Qaboos University medical journal,2017,pubmed,clinical
PMID:29342057,Audiologic Natural History of Small Volume Cochleovestibular Schwannomas in Neurofibromatosis Type 2.,10.1097/MAO.0000000000001690,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",2018,pubmed,clinical
PMID:29139538,Limitations of the Pax7-creER,10.1387/ijdb.170182as,The International journal of developmental biology,2017,pubmed,clinical
PMID:28848060,Genetic Severity Score predicts clinical phenotype in NF2.,10.1136/jmedgenet-2017-104519,Journal of medical genetics,2017,pubmed,clinical
PMID:28814319,Constipation in adults with neurofibromatosis type 1.,10.1186/s13023-017-0691-4,Orphanet journal of rare diseases,2017,pubmed,clinical
PMID:28735371,Identifying Symptoms of Distress in Youth Living with Neurofibromatosis Type 1 (NF1).,10.1007/s10897-017-0128-1,Journal of genetic counseling,2018,pubmed,clinical
PMID:28644838,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",10.1371/journal.pone.0178639,PloS one,2017,pubmed,clinical
PMID:28193237,Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire.,10.1186/s12955-017-0607-y,Health and quality of life outcomes,2017,pubmed,clinical
PMID:28138125,Face Transplant in an Advanced Neurofibromatosis Type 1 Patient.,10.12659/aot.900617,Annals of transplantation,2017,pubmed,clinical
PMID:27956565,Randomized placebo-controlled study of lovastatin in children with neurofibromatosis type 1.,10.1212/WNL.0000000000003435,Neurology,2016,pubmed,clinical
PMID:27817916,Orbital/Periorbital Plexiform Neurofibromas in Children with Neurofibromatosis Type 1: Multidisciplinary Recommendations for Care.,10.1016/j.ophtha.2016.09.020,Ophthalmology,2017,pubmed,clinical
PMID:27527648,Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trials.,10.1212/WNL.0000000000002927,Neurology,2016,pubmed,clinical
PMID:27527646,Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.,10.1212/WNL.0000000000002928,Neurology,2016,pubmed,clinical
PMID:27516813,Sex bias in autism spectrum disorder in neurofibromatosis type 1.,10.1186/s11689-016-9159-4,Journal of neurodevelopmental disorders,2016,pubmed,clinical
PMID:27385209,"Co-expression modules of NF1, PTEN and sprouty enable distinction of adult diffuse gliomas according to pathway activities of receptor tyrosine kinases.",10.18632/oncotarget.10359,Oncotarget,2016,pubmed,clinical
PMID:27236462,The importance of nerve microenvironment for schwannoma development.,10.1007/s00401-016-1583-8,Acta neuropathologica,2016,pubmed,clinical
PMID:27122017,Surgically treated solitary giant gluteal and retroperitoneal neurofibroma: a case report.,10.1186/s12957-016-0880-y,World journal of surgical oncology,2016,pubmed,clinical
PMID:27081657,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,10.1002/acn3.288,Annals of clinical and translational neurology,2016,pubmed,clinical
PMID:27057895,Surgical Treatment of Dystrophic Spinal Curves Caused by Neurofibromatosis Type 1: A Retrospective Study of 26 Patients.,10.1097/MD.0000000000003292,Medicine,2016,pubmed,clinical
PMID:27021207,Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy.,10.1002/ajmg.a.37623,American journal of medical genetics. Part A,2016,pubmed,clinical
PMID:27018750,Peri-gestational risk factors for pediatric brain tumors in Neurofibromatosis Type 1.,10.1016/j.canep.2016.03.005,Cancer epidemiology,2016,pubmed,clinical
PMID:26783591,"Is Participating in Psychological Research a Benefit, Burden, or Both for Medically Ill Youth and Their Caregivers?",,IRB,2015,pubmed,clinical
PMID:26773288,Executive functioning deficits in children with neurofibromatosis type 1: The influence of intellectual and social functioning.,10.1002/ajmg.b.32414,"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics",2016,pubmed,clinical
PMID:26758488,Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome.,10.4274/jcrpe.2070,Journal of clinical research in pediatric endocrinology,2016,pubmed,clinical
PMID:26666764,Associations between allergic conditions and pediatric brain tumors in Neurofibromatosis type 1.,10.1007/s10689-015-9855-3,Familial cancer,2016,pubmed,clinical
PMID:26664443,Painless Loss of Vision as The First Presentation of Undiagnosed Neurofibromatosis 1 in A Child.,,Iranian journal of child neurology,2015,pubmed,clinical
PMID:26657314,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,10.1371/journal.pone.0144620,PloS one,2015,pubmed,clinical
PMID:26519538,Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.,10.1212/WNL.0000000000002118,Neurology,2016,pubmed,clinical
PMID:26473019,"Cerebral volumetric abnormalities in Neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms.",10.1186/s11689-015-9128-3,Journal of neurodevelopmental disorders,2015,pubmed,clinical
PMID:26104281,Multiple synchronous sites of origin of vestibular schwannomas in neurofibromatosis Type 2.,10.1136/jmedgenet-2015-103050,Journal of medical genetics,2015,pubmed,clinical
PMID:26083891,Neurofibromatosis: part 2--clinical management.,10.1590/0004-282X20150042,Arquivos de neuro-psiquiatria,2015,pubmed,clinical
PMID:25990002,Choroidal abnormalities in neurofibromatosis type 1 detected by near-infrared reflectance imaging in paediatric population.,10.1111/aos.12750,Acta ophthalmologica,2015,pubmed,clinical
PMID:25976979,"Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social-emotional functioning, and quality of life.",10.1002/ajmg.a.37123,American journal of medical genetics. Part A,2015,pubmed,clinical
PMID:25962619,"ADHD-associated dopamine transporter, latrophilin and neurofibromin share a dopamine-related locomotor signature in Drosophila.",10.1038/mp.2015.55,Molecular psychiatry,2016,pubmed,clinical
PMID:25742877,"Delayed diagnosis of childhood low-grade glioma: causes, consequences, and potential solutions.",10.1007/s00381-015-2670-1,Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery,2015,pubmed,clinical
PMID:25710373,Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysis.,10.1371/journal.pmed.1001789,PLoS medicine,2015,pubmed,clinical
PMID:25616962,FGFR1 signaling in hypertrophic chondrocytes is attenuated by the Ras-GAP neurofibromin during endochondral bone formation.,10.1093/hmg/ddv019,Human molecular genetics,2015,pubmed,clinical
PMID:25557241,Outcomes of preimplantation genetic diagnosis in neurofibromatosis type 1.,10.1016/j.fertnstert.2014.11.021,Fertility and sterility,2015,pubmed,clinical
PMID:25534182,Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life.,10.1111/cge.12551,Clinical genetics,2015,pubmed,clinical
PMID:25377441,Development and validation of the English Pain Interference Index and Pain Interference Index-Parent report.,10.1111/pme.12620,"Pain medicine (Malden, Mass.)",2015,pubmed,clinical
PMID:25364327,Hydrocephalus following bilateral dumbbell-shaped c2 spinal neurofibromas resection and postoperative cervical pseudomeningocele in a patient with neurofibromatosis type 1: a case report.,10.1055/s-0034-1387805,Evidence-based spine-care journal,2014,pubmed,clinical
PMID:25043591,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,10.1002/jbmr.2316,Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,2015,pubmed,clinical
PMID:24753394,Phase II trial of pirfenidone in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.,10.1002/pbc.25041,Pediatric blood & cancer,2014,pubmed,clinical
PMID:24676443,Neurofibromatoses: part 1 - diagnosis and differential diagnosis.,10.1590/0004-282x20130241,Arquivos de neuro-psiquiatria,2014,pubmed,clinical
PMID:24619350,Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2.,10.1007/s00415-014-7303-1,Journal of neurology,2014,pubmed,clinical
PMID:24582430,[Neurofibromatosis type 2 and its head and neck manifestations: literature review and population study in the Community of Cantabria and the province of Las Palmas].,10.1016/j.otorri.2013.12.001,Acta otorrinolaringologica espanola,2014,pubmed,clinical
PMID:24500418,"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas.",10.1093/neuonc/nou004,Neuro-oncology,2014,pubmed,clinical
PMID:24249806,Patient-reported outcomes in neurofibromatosis and schwannomatosis clinical trials.,10.1212/01.wnl.0000435747.02780.bf,Neurology,2013,pubmed,clinical
PMID:24249805,Conclusions and future directions for the REiNS International Collaboration.,10.1212/01.wnl.0000435748.79908.c5,Neurology,2013,pubmed,clinical
PMID:24249804,Recommendations for imaging tumor response in neurofibromatosis clinical trials.,10.1212/01.wnl.0000435744.57038.af,Neurology,2013,pubmed,clinical
PMID:24249802,Functional outcome measures for NF1-associated optic pathway glioma clinical trials.,10.1212/01.wnl.0000435745.95155.b8,Neurology,2013,pubmed,clinical
PMID:24249801,Achieving consensus for clinical trials: the REiNS International Collaboration.,10.1212/01.wnl.0000435743.49414.b6,Neurology,2013,pubmed,clinical
PMID:24197987,Vision specific quality of life in children with optic pathway gliomas.,10.1007/s11060-013-1300-6,Journal of neuro-oncology,2014,pubmed,clinical
PMID:24101678,Autism traits in the RASopathies.,10.1136/jmedgenet-2013-101951,Journal of medical genetics,2014,pubmed,clinical
PMID:24065580,Prevalence of Sleep Disturbances in Children With Neurofibromatosis Type 1.,10.1177/0883073813500849,Journal of child neurology,2013,pubmed,clinical
PMID:23863460,Hyperactive Ras/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice.,10.1093/hmg/ddt333,Human molecular genetics,2013,pubmed,clinical
PMID:23853621,A Novel Medical Treatment of Cushing's Due to Ectopic ACTH in a Patient With Neurofibromatosis Type 1.,10.5812/ijem.6898,International journal of endocrinology and metabolism,2013,pubmed,clinical
PMID:23446537,"[Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].",,Turk psikiyatri dergisi = Turkish journal of psychiatry,2013,pubmed,clinical
PMID:23432799,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",10.1186/1477-7525-11-21,Health and quality of life outcomes,2013,pubmed,clinical
PMID:23412344,Depletion of the novel p53-target gene carnitine palmitoyltransferase 1C delays tumor growth in the neurofibromatosis type I tumor model.,10.1038/cdd.2012.168,Cell death and differentiation,2013,pubmed,clinical
PMID:23239957,LEOPARD Syndrome: Clinical Features and Gene Mutations.,10.1159/000342251,Molecular syndromology,2012,pubmed,clinical
PMID:23205844,"Understanding relationships between autism, intelligence, and epilepsy: a cross-disorder approach.",10.1111/dmcn.12044,Developmental medicine and child neurology,2013,pubmed,clinical
PMID:23197650,Heterozygous inactivation of the Nf1 gene in myeloid cells enhances neointima formation via a rosuvastatin-sensitive cellular pathway.,10.1093/hmg/dds502,Human molecular genetics,2013,pubmed,clinical
PMID:23185366,The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells.,10.1371/journal.pone.0049570,PloS one,2012,pubmed,clinical
PMID:23163236,Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study.,10.1111/dmcn.12043,Developmental medicine and child neurology,2013,pubmed,clinical
PMID:23066466,Genitourinary plexiform neurofibroma mimicking sacrococcygeal teratoma.,10.4103/2006-8808.100356,Journal of surgical technique and case report,2012,pubmed,clinical
PMID:23056937,"Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1.",10.1155/2012/975364,Pain research and treatment,2012,pubmed,clinical
PMID:22961690,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,10.1002/pbc.24281,Pediatric blood & cancer,2013,pubmed,clinical
PMID:22858714,Radiographic association of schwannomas with sensory ganglia.,10.1097/MAO.0b013e318263d315,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",2012,pubmed,clinical
PMID:22821737,The Learning Disabilities Network (LeaDNet): using neurofibromatosis type 1 (NF1) as a paradigm for translational research.,10.1002/ajmg.a.35535,American journal of medical genetics. Part A,2012,pubmed,clinical
PMID:24936445,Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.,10.1016/j.jccw.2013.06.001,The journal of the American College of Clinical Wound Specialists,2012,pubmed,clinical
PMID:21963267,Choroidal abnormalities detected by near-infrared reflectance imaging as a new diagnostic criterion for neurofibromatosis 1.,10.1016/j.ophtha.2011.07.046,Ophthalmology,2012,pubmed,clinical
PMID:21750756,Solitary penile neurofibroma with erectile dysfunction.,10.4111/kju.2011.52.6.428,Korean journal of urology,2011,pubmed,clinical
PMID:21495177,Observations on intelligence and behavior in 15 patients with Legius syndrome.,10.1002/ajmg.c.30297,"American journal of medical genetics. Part C, Seminars in medical genetics",2011,pubmed,clinical
PMID:21451418,Empirical development of improved diagnostic criteria for neurofibromatosis 2.,10.1097/GIM.0b013e318211faa9,Genetics in medicine : official journal of the American College of Medical Genetics,2011,pubmed,clinical
PMID:21347399,"Neurofibromatosis type 1 and the ""elephant man's"" disease: the confusion persists: an ethnographic study.",10.1371/journal.pone.0016409,PloS one,2011,pubmed,clinical
PMID:21272240,"Feasibility, reproducibility, risks and benefits of face transplantation: a prospective study of outcomes.",10.1111/j.1600-6143.2010.03406.x,American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,2011,pubmed,clinical
PMID:21224727,Autophagy blockade enhances HDAC inhibitors' pro-apoptotic effects: potential implications for the treatment of a therapeutic-resistant malignancy.,10.4161/auto.7.4.14680,Autophagy,2011,pubmed,clinical
PMID:21153564,Health-related quality of life in preschool children in five health conditions.,10.1007/s11136-010-9806-2,"Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation",2011,pubmed,clinical
PMID:20951236,"Experiences of families with a child, adolescent, or young adult with neurofibromatosis type 1 and plexiform neurofibroma evaluated for clinical trials participation at the National Cancer Institute.",10.1016/j.cct.2010.10.004,Contemporary clinical trials,2011,pubmed,clinical
PMID:20920304,"Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma.",10.1186/1471-2164-11-532,BMC genomics,2010,pubmed,clinical
PMID:20736812,Erlotinib for progressive vestibular schwannoma in neurofibromatosis 2 patients.,10.1097/MAO.0b013e3181eb328a,"Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology",2010,pubmed,clinical
PMID:20187887,"Application of the International Classification of Functioning, Disability and Health in children with neurofibromatosis type 1: a review.",10.1111/j.1469-8749.2010.03624.x,Developmental medicine and child neurology,2010,pubmed,clinical
PMID:22798089,Pulmonary arterial hypertension associated with neurofibromatosis type 1.,10.1136/bcr.05.2010.2961,BMJ case reports,2010,pubmed,clinical
PMID:19690597,[Neurofibromatosis type 2 and auditory brainstem implantation].,10.4045/tidsskr.08.0151,"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke",2009,pubmed,clinical
PMID:19621444,Health-related quality of life measures in genetic disorders: an outcome variable for consideration in clinical trials.,10.1002/ajmg.c.30217,"American journal of medical genetics. Part C, Seminars in medical genetics",2009,pubmed,clinical
PMID:19610677,Transition state structures and the roles of catalytic residues in GAP-facilitated GTPase of Ras as elucidated by (18)O kinetic isotope effects.,10.1021/bi802359b,Biochemistry,2009,pubmed,clinical
PMID:19245780,[Surgical treatment of vagal paragangliomas].,,Acta otorrinolaringologica espanola,2009,pubmed,clinical
PMID:19164945,Pediatric low-grade gliomas and the need for new options for therapy: Why and how?,10.4161/cbt.8.1.7237,Cancer biology & therapy,2009,pubmed,clinical
PMID:18952585,Using neurofibromatosis-1 to better understand and treat pediatric low-grade glioma.,10.1177/0883073808321061,Journal of child neurology,2008,pubmed,clinical
PMID:18632543,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,10.1001/jama.300.3.287,JAMA,2008,pubmed,clinical
PMID:17202204,Refractive errors in neurofibromatosis type 1 and type 2.,10.1136/bjo.2006.109082,The British journal of ophthalmology,2007,pubmed,clinical
PMID:15832546,Psychological disturbance and sleep disorders in children with neurofibromatosis type 1.,10.1017/s0012162205000460,Developmental medicine and child neurology,2005,pubmed,clinical
PMID:15712001,Spinal deformity in neurofibromatosis type-1: diagnosis and treatment.,10.1007/s00586-004-0829-7,"European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society",2005,pubmed,clinical
PMID:15647118,Patient-focused measures of functional health status and health-related quality of life in pediatric orthopedics: a case study in measurement selection.,10.1186/1477-7525-3-3,Health and quality of life outcomes,2005,pubmed,clinical
PMID:15286864,[Puberty and growth in children and adolescents with neuro fibromatosis type 1].,10.1590/s0104-42302004000200032,Revista da Associacao Medica Brasileira (1992),2004,pubmed,clinical
PMID:12067169,Vertebral scalloping in neurofibromatosis type 1: a quantitative approach.,,Canadian journal of surgery. Journal canadien de chirurgie,2002,pubmed,clinical
PMID:11981218,Adrenalectomy for familial pheochromocytoma in the laparoscopic era.,10.1097/00000658-200205000-00014,Annals of surgery,2002,pubmed,clinical
PMID:20667203,Diagnosis and endovascular treatment of vertebral arteriovenous fistulas in neurofibromatosis type 1.,10.1177/159101990000600310,"Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences",2000,pubmed,clinical
PMID:11106357,Growth in North American white children with neurofibromatosis 1 (NF1).,10.1136/jmg.37.12.933,Journal of medical genetics,2000,pubmed,clinical
PMID:10547131,"Physicians' decision-making in incompetent elderly patients: a comparative study between Austria, Germany (East, West), and Sweden.",10.1017/s1041610299005876,International psychogeriatrics,1999,pubmed,clinical
PMID:10053020,The duty to recontact: attitudes of genetics service providers.,10.1086/302293,American journal of human genetics,1999,pubmed,clinical
PMID:9055157,Tribute--and a clinical lesson in bioethics and quality of life.,10.1136/jme.23.1.18,Journal of medical ethics,1997,pubmed,clinical
PMID:8719691,Neurofibromatosis type 1 in children.,,Transactions of the American Ophthalmological Society,1995,pubmed,clinical
PMID:7818486,Activation of Ito cells involves regulation of AP-1 binding proteins and induction of type I collagen gene expression.,10.1042/bj3040817,The Biochemical journal,1994,pubmed,clinical
PMID:1883874,"sar1, a gene from Schizosaccharomyces pombe encoding a protein that regulates ras1.",10.1091/mbc.2.6.453,Cell regulation,1991,pubmed,clinical
PMID:2500456,"Type 1 neurofibromatosis: selective expression of extracellular matrix genes by Schwann cells, perineurial cells, and fibroblasts in mixed cultures.",10.1172/JCI114148,The Journal of clinical investigation,1989,pubmed,clinical
PMID:3149306,Neurofibromatosis in Nigerian children.,,Journal of the National Medical Association,1988,pubmed,clinical
PMID:3082351,Childhood chiasmal gliomas: update on the fate of patients in the 1969 San Francisco Study.,10.1136/bjo.70.3.179,The British journal of ophthalmology,1986,pubmed,clinical
PMID:146075,Tumours of the cauda equina.,10.1136/jnnp.41.1.24,"Journal of neurology, neurosurgery, and psychiatry",1978,pubmed,clinical
